Home » Newsletters » BioWorld Science

BioWorld Science

July 22, 2021

View Archived Issues

New CRISPR-Cas vector designs reduce vector size and increase vector titer for HIV/AIDS treatment

Studies show NNRTI MK-8507 can be used with islatravir, levonorgestrel/ethinyl estradiol

FDA approves IND for phase I/II study of Zofin in COVID-19 long haulers

FDA clears IND for Viracta's all-oral combination regimen in EBV-positive solid tumors

Positive data reported from phase Ib study of IMT-002 in T1D with HLA-DQ8 trait

Medshine Discovery patents new KHK inhibitors for NASH

Sorrento initiates dosing in U.K. phase II study of COVI-DROPS in outpatient setting

Positive phase II data for eprenetapopt plus azacitidine in TP53 mutant MDS and AML

IRF7 and PTDSS2 are therapeutic targets in HIV-1 infection

IFM Due divulges hSTING antagonists

Tyra Biosciences presents new FGFR inhibitors

R-107 shows the ability to prevent, treat and reverse established PAH in vivo

Rheos Medicines discloses MALT1 inhibitors

Apoptosis inhibitors show promise in severe TB models

Eureka initiates phase I/II ARYA-3 study of ECT-204 in liver cancer

Dicerna provides interim data from phase I study of belcesiran in AATLD

XPB shown to regulate HIV-1 transcriptional activity

Antengene obtains HREC approval in Australia for phase I study of ATG-101 in solid tumors and NHL

Addition of CF-296 to SOC leads to enhanced antibacterial activity against MSSA and MRSA isolates

Amplia reports phase I data on AMP-945

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...